RxDoctor Payments Data

Ralph Hellams, MD

Family Medicine · Manakin Sabot, VANPI 1053380352

Payments from drug & device makers

$1,820in general payments, 2019–2025

Across 99 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$286
  • UCB, Inc.$169
  • Sumitomo Pharma America, Inc.$129
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$114
  • Bayer$107
  • Pfizer$102
  • plus $913 from 20 others

What the payments were for

  • Food & beverage$1,73595%
  • Education$855%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,820 in reported general payments places this provider in the 75th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$229,947
Medicare patients
245
Services billed
2,183

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban163$58,174
TrulicityDulaglutide37$35,437
JanuviaSitagliptin Phosphate42$23,283
XareltoRivaroxaban60$18,942
OzempicSemaglutide11$14,152
JardianceEmpagliflozin25$11,043
SantylCollagenase Clostridium Hist.14$10,932
Potassium Chloride169$9,967
Erythromycin Ethylsuccinate29$9,752
Pantoprazole Sodium182$8,537
GemtesaVibegron25$6,072
FarxigaDapagliflozin Propanediol11$5,764
Fluticasone-SalmeterolFluticasone Propion/Salmeterol28$5,168
Atorvastatin Calcium347$4,309
Midodrine Hcl24$4,204

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$102$58,174163 claims
Lilly USA, LLCTrulicity$80$35,43737 claims
MerckJanuvia$19$23,28342 claims
Johnson & JohnsonXarelto$21$18,94260 claims
Novo NordiskOzempic$80$14,15211 claims
Sumitomo Pharma America, Inc.Gemtesa$129$6,07225 claims
AstraZenecaFarxiga$32$5,76411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Manakin Sabot

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →